<DOC>
	<DOCNO>NCT01611584</DOCNO>
	<brief_summary>The purpose trial measure ALA-induced fluorescence normal malignant tissue .</brief_summary>
	<brief_title>A Proof Principle Study Aminolevulinic Acid ( ALA ) - Induced Fluorescence Detection Resectable Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>Inclusion Criteria Patients ( 12 total patient lung cancer ) meeting eligibility criterion enrol . Preoperative diagnosis either presume documented nonsmall cell lung cancer . Tumor judge suitable surgical resection base preoperative evaluation radiographic study , pulmonary function test , performance status clinical judgment surgeon DHMC ( Erkmen , Nugent ) Age â‰¥ 18 year old . Population representative usual referral pattern include minority population , woman financially disadvantage . Subjects capable give informed consent Pregnant Women Women breast feeding History cutaneous photosensitivity Porphyria , hypersensitivity porphyrin , photodermatosis Exfoliative dermatitis History liver disease within last 12 month Inability comply photosensitivity precaution associate study Inability give inform consent AST , ALT , ALP bilirubin level great 2.5 time normal limit time past 2 month Plasma creatinine excess 180 umol/L Women breast feed History cutaneous photosensitivity Porphyria , hypersensitivity porphyrin , photodermatosis Exfoliative dermatitis History liver disease within last 12 month Inability comply photosensitivity precaution associate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>ALA</keyword>
	<keyword>Florescence</keyword>
	<keyword>Lung cancer</keyword>
</DOC>